Opiod addicts now have a new tool to help them battle their addiction now that the Federal Drug Administration has approved the first implantable medication device.

A story at fox6now.com describes how the implant delivers buprenorphine to help keep cravings under control and prevent relapse for a period of about six months. The goal is to help wean addicts off drugs like heroin.

Dr. Robert M. Califf is commissioner of the FDA, and he noted in the announcement the devastating affect heroin has had on families.

“Opioid abuse and addiction have taken a devastating toll on American families,” he is quoted as saying. “We must do everything we can to make new, innovative treatment options available that can help patients regain control over their lives.”

The Centers for Disease Control lists more than 28,000 people who died in 2014 because of opiod addiction, the story continues.

 

Love what we do?

In addition to our education features, we’ll be kicking off a series of stories highlighting how parents, students, and educators are adapting to the impact of COVID-19 on education. If this is important to you, please consider donating to our education reporting fund. https://business.facebook.com/donate/1846323118855149/3262802717172659/